MARYLAND CAPITAL ADVISORS INC.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1891201
CHESTER, MD
Position in REGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$40,530
-$9,641 QoQ
Shares Held
65
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,111
of 1,297 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARYLAND CAPITAL ADVISORS INC. holds $43,252 across 15 Biotechnology names. REGN ranks #1 (93.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
65 | $40,530 | |
| 2 | NVAX |
Novavax Inc
|
173 | $1,629 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5 | $176 | |
| 4 | EXEL |
Exelixis, Inc.
|
3 | $163 | |
| 5 | MRNA |
Moderna, Inc.
|
2 | $140 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
2 | $114 | |
| 7 | INCY |
Incyte Corp
|
1 | $113 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1 | $81 |
All Filings in REGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,530 | 65 | Shares | Sole | 2026-07-17 | |
| 2025-12-31 | $50,171 | 65 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $36,547 | 65 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $34,125 | 65 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $41,224 | 65 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $46,301 | 65 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $136,661 | 130 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $136,633 | 130 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $125,123 | 130 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $114,177 | 130 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $106,984 | 130 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $93,410 | 130 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $106,817 | 130 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $93,793 | 130 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $89,553 | 130 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $76,846 | 130 | Shares | Sole | 2022-07-25 | |
| No filing history on record for this holder in this stock. | ||||||